Search results
Results from the WOW.Com Content Network
Androgen replacement therapy formulations and dosages used in men Route Medication Major brand names Form Dosage Oral: Testosterone a – Tablet: 400–800 mg/day (in divided doses) Testosterone undecanoate: Andriol, Jatenzo: Capsule: 40–80 mg/2–4× day (with meals) Methyltestosterone b: Android, Metandren, Testred: Tablet: 10–50 mg/day ...
This is a list of abbreviations used in medical prescriptions, including hospital orders (the patient-directed part of which is referred to as sig codes). This list does not include abbreviations for pharmaceuticals or drug name suffixes such as CD, CR, ER, XT (See Time release technology § List of abbreviations for those).
q.s., qs a sufficient quantity quantum sufficiat: q.wk. also qw weekly (once a week) quaque week Rx, R x, ℞ ...
See the do-not-use list) QIDS: Quick Inventory of Depressive Symptoms: q.l. as much as you like (from Latin quantum libet) q.m.t. also qm: every month q.n. every night QNS q.n.s. quantity not sufficient q.o.d. every other day (from Latin quaque altera die) (deprecated; use "every other day" instead. See the do-not-use list) QOF
Get AOL Mail for FREE! Manage your email like never before with travel, photo & document views. Personalize your inbox with themes & tabs. You've Got Mail!
Dosage typically includes information on the number of doses, intervals between administrations, and the overall treatment period. [3] For example, a dosage might be described as "200 mg twice daily for two weeks," where 200 mg represents the individual dose, twice daily indicates the frequency, and two weeks specifies the duration of treatment.
SYSTEM REQUIREMENTS. Mobile and desktop browsers: Works best with the latest version of Chrome, Edge, FireFox and Safari. Windows: Windows 7 and newer Mac: MacOS X and newer Note: Ad-Free AOL Mail ...
Template:Medications and dosages used in hormone therapy for transgender men References ^ Hembree WC, Cohen-Kettenis PT, Gooren L, Hannema SE, Meyer WJ, Murad MH, Rosenthal SM, Safer JD, Tangpricha V, T'Sjoen GG (November 2017).